The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Specific Binding of Chromosomal Protein HMG1 to DNA Damaged by the Anticancer Drug Cisplatin
Abstract
The mechanism of action of the anticancer compound cis -diamminedichloroplatinum(II) (cisplatin) involves covalent binding to DNA. In an effort to understand the tumor-specific cytotoxicity of such DNA damage, the interactions of these lesions with cellular proteins have been studied. One such protein has been identified as the high-mobility group protein HMG1. Recombinant rat HMG1 binds specifically (dissociation constant 3.7 ± 2.0 × 10 -7 molar) to DNA containing cisplatin d(GpG) or d(ApG) intrastrand cross-links, which unwind and bend DNA in a specific manner, but not to DNA modified by therapeutically inactive platinum analogs. These results suggest how HMG1 might bind to altered DNA structures and may be helpful in designing new antitumor drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260
Fichtinger-Schepman, A. M. J., Van der Veer, J. L., Den Hartog, J. H. J., Lohman, P. H. M., & Reedijk, J. (1985) · Biochemistry · doi:10.1021/bi00324a025 · Cited by 1,024
Nucleolar transcription factor hUBF contains a DNA-binding motif with homology to HMG proteins
Jantzen, H.-M., Admon, A., Bell, S. P., & Tjian, R. (1990) · Nature · doi:10.1038/344830a0 · Cited by 645
Specific Recognition of Cruciform DNA by Nuclear Protein HMG1
Bianchi, M. E., Beltrame, M., & Paonessa, G. (1989) · Science · doi:10.1126/science.2922595 · Cited by 601
Eastman, A. (1987) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(87)90009-x · Cited by 539
Structural features of the HMG chromosomal proteins and their genes
Bustin, M., A. Lehn, D., & Landsman, D. (1990) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(90)90092-g · Cited by 469
Xeroderma Pigmentosum Group E Cells Lack a Nuclear Factor That Binds to Damaged DNA
Chu, G., & Chang, E. (1988) · Science · doi:10.1126/science.3175673 · Cited by 416
Bellon, S. F., Coleman, J. H., & Lippard, S. J. (1991) · Biochemistry · doi:10.1021/bi00246a021 · Cited by 291
Self-citationDNA-binding properties of the HMG domain of the lymphoid-specific transcriptional regulator LEF-1.
Giese, K., Amsterdam, A., & Grosschedl, R. (1991) · Genes & Development · doi:10.1101/gad.5.12b.2567 · Cited by 265
Bruhn, S. L., Pil, P. M., Essigmann, J. M., Housman, D. E., & Lippard, S. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2307 · Cited by 248
Self-citation
Cited by
Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00597 · Cited by 2,485
Self-citationKang, R., Chen, R., Zhang, Q., Hou, W., Wu, S., Cao, L., Huang, J., Yu, Y., Fan, X.-G., Yan, Z., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.05.001 · Cited by 956
HMG domain proteins: architectural elements in the assembly of nucleoprotein structures
Grosschedl, R., Giese, K., & Pagel, J. (1994) · Trends in Genetics · doi:10.1016/0168-9525(94)90232-1 · Cited by 813
(2004) · Forensic Botany · doi:10.1201/9780203484593-10 · Cited by 787
Bustin, M., & Reeves, R. (1996) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60360-8 · Cited by 763
Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair.
Chu, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42175-2 · Cited by 651
Lotze, M. T., Zeh, H. J., Rubartelli, A., Sparvero, L. J., Amoscato, A. A., Washburn, N. R., DeVera, M. E., Liang, X., Tör, M., & Billiar, T. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00579.x · Cited by 641
Cisplatin: From DNA damage to cancer chemotherapy
Cohen, S. M., & Lippard, S. J. (2001) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(01)67026-0 · Cited by 615
Self-citationHMGB proteins: Interactions with DNA and chromatin
Štros, M. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.09.008 · Cited by 611
Improved understanding in platinium antitumour chemistry
Reedijk, J. (1996) · Chemical Communications · doi:10.1039/cc9960000801 · Cited by 589
Structural basis for DNA bending by the architectural transcription factor LEF-1
Love, J. J., Li, X., Case, D. A., Giese, K., Grosschedl, R., & Wright, P. E. (1995) · Nature · doi:10.1038/376791a0 · Cited by 573
Mechanisms of DNA Excision Repair
Sancar, A. (1994) · Science · doi:10.1126/science.7801120 · Cited by 555
SRY, like HMG1, recognizes sharp angles in DNA.
Ferrari, S., Harley, V. R., Pontiggia, A., Goodfellow, P. N., Lovell-Badge, R., & Bianchi, M. E. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05551.x · Cited by 441
Duckett, D. R., Drummond, J. T., Murchie, A. I., Reardon, J. T., Sancar, A., Lilley, D. M., & Modrich, P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6443 · Cited by 421
Crystal Structure of the Anticancer Drug Cisplatin Bound to Duplex DNA
Takahara, P. M., Frederick, C. A., & Lippard, S. J. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9625079 · Cited by 405
Self-citationStructure of the HMG box motif in the B-domain of HMG1.
Weir, H. M., Kraulis, P. J., Hill, C. S., Raine, A. R., Laue, E. D., & Thomas, J. O. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05776.x · Cited by 403
Metallomics as integrated biometal science
Haraguchi, H. (2004) · Journal of Analytical Atomic Spectrometry · doi:10.1039/b308213j · Cited by 399
Recognition and processing of cisplatin- and oxaliplatin-DNA adducts
Chaney, S. G., Campbell, S. L., Bassett, E., & Wu, Y. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.08.008 · Cited by 396
Kimura, K., & Hirano, T. (1997) · Cell · doi:10.1016/s0092-8674(00)80524-3 · Cited by 383
The multifunctional protein HMGB1: 50 years of discovery
Tang, D., Kang, R., Zeh, H. J., & Lotze, M. T. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00894-6 · Cited by 371
Duan, X., Li, Y., Rajan, N. K., Routenberg, D. A., Modis, Y., & Reed, M. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.82 · Cited by 366
Recognition of cisplatin adducts by cellular proteins
Kartalou, M., & Essigmann, J. M. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00142-7 · Cited by 349
Huang, J. C., Zamble, D. B., Reardon, J. T., Lippard, S. J., & Sancar, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10394 · Cited by 347
Self-citationAn overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies
Musumeci, D., Roviello, G. N., & Montesarchio, D. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.001 · Cited by 334
Paull, T. T., Haykinson, M. J., & Johnson, R. C. (1993) · Genes & Development · doi:10.1101/gad.7.8.1521 · Cited by 323
High mobility group protein-1 (HMG-1) is a unique activator of p53
Jayaraman, L., Moorthy, N. C., Murthy, K. G. K., Manley, J. L., Bustin, M., & Prives, C. (1998) · Genes & Development · doi:10.1101/gad.12.4.462 · Cited by 321
Drummond, J. T., Anthoney, A., Brown, R., & Modrich, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19645 · Cited by 295
Arnesano, F., & Natile, G. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.01.028 · Cited by 282
Metal Compounds in Therapy and Diagnosis
Abrams, M. J., & Murrer, B. A. (1993) · Science · doi:10.1126/science.8102010 · Cited by 281
DNA Repair: Enzymatic Mechanisms and Relevance to Drug Response
Chaney, S. G., & Sancar, A. (1996) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/88.19.1346 · Cited by 280
Gadd45, a p53-Responsive Stress Protein, Modifies DNA Accessibility on Damaged Chromatin
Carrier, F., Georgel, P. T., Pourquier, P., Blake, M., Kontny, H. U., Antinore, M. J., Gariboldi, M., Myers, T. G., Weinstein, J. N., Pommier, Y., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1673 · Cited by 277
Solution structure of a DNA-binding domain from HMG1
Read, C. M., Cary, P. D., Crane-Robinson, C., Driscoll, P. C., & Norman, D. G. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.15.3427 · Cited by 272
Sancar, A., & Tang, M. (1993) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1993.tb09233.x · Cited by 258
Nuclear functions of the HMG proteins
Reeves, R. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.09.001 · Cited by 254
Effect of oxidative DNA damage in promoter elements on transcription factor binding
Ghosh, R., & Mitchell, D. L. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.15.3213 · Cited by 152
High-Affinity Binding of Tumor-Suppressor Protein p53 and HMGB1 to Hemicatenated DNA Loops
Štros, M., Muselíková-Polanská, E., Pospíšilová, Š., & Strauss, F. (2004) · Biochemistry · doi:10.1021/bi049928k · Cited by 81
Love, J. J., Li, X., Chung, J., Dyson, H. J., & Wright, P. E. (2004) · Biochemistry · doi:10.1021/bi049591m · Cited by 66
Metadata
- Authors
- Pil, P. M., & Lippard, S. J.
- Venue
- Science
- Published
- 1992-04-10
- Volume
- 256
- Issue
- 5054
- Pages
- 234-237
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2090995659
- Cited by
- 496
- References
- 20
- FWCI
- 16.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.